A serially transplantable perianal gland carcinoma (CAC-9) was developed in nude mice from a hypercalcemic dog that has been maintained through passage 20. Tumor doubling rate of CAC-9 was 3.1 * 0.4 days. Mithramycin (MMC) injected intraperitoneally (8 mg/kg) into nude mice bearing CAC-9 markedly decreased the tumor volume 2 weeks post-injection. MMC returned the elevated serum and urine calcium levels in mice with CAC-9 back to similar values as controls. The few remaining viable tumor cells after MMC were large and had numerous aggregations of intermediate filaments that displaced cytoplasmic organelles. Histomorphometric evaluation of lumbar vertebrae reveled no significant differences in bone resorption of nude mice bearing CAC-9 compared to saline-treated controls. This rapidly growing tumor line in nude mice associated with mild hypercalcemia will be a useful animal model to evaluate combinations of chemotherapy for cancerassociated hypercalcemia.
Mithramycin (MMC) is a potent anti-cancer drug commonly used to treat cancer in human beings. The mechanism of action of MMC appears to be due to an inhibition of DNA-directed RNA synthesis. Since MMC can inhibit bone resorption, it has been used in the medical management of certain forms of hypercalcemia associated with malignancy. ' 1.16.21 Several investigators have reported that MMC was effective in producing regression of human tumor xenographs in athymic nude mice.4,1s,24 However, ultrastructural and biochemical studies have not been reported on the effects of MMC on transplanted hypercalcemia-producing tumors from either human or animal patients.
Malignancy-associated hypercalcemia is a common paraneoplastic syndrome recognized in human being^'.'^,'^ and Hypercalcemia may result from two different mechanisms: 1) local osteolysis of bone due to tumor cells in the bone marrow, e.g., lymphosarcoma, and 2) the release of humoral factors from neoplastic cells which result in bone resorption distant to the site of the tumor. The latter syndrome is termed humoral hypercalcemia of malignancy (HHM) and commonly occurs in dogs with adenocarcinomas derived from apocrine glands of the anal sac. 19 The nude mouse has been a useful animal for the study of xenografted tissue. 6 Rosol et al. have recently described a serially transplantable tumor (CAC-8) originating from an anal sac adenocarcinoma derived from apocrine glands of the anal sac of a hypercalcemic dog and which consistently reproduces the syndrome of HHM in nude mice.I9 Several human tumors produce hypercalcemia when transplanted in the nude mouse including squamous cell carcinoma' and a renal cell carcinoma. 22 The specific objectives of this investigation were: 1) to develop a serially transplantable tumor line (CAC-9) in nude mice from a perianal gland carcinoma of a dog with mild hypercalcemia, 2) to determine tumor growth rate, serum calcium and phosphorus, and urinary excretion of calcium and phosphorus in nude mice with successful tumor transplants, and 3) to investigate the effects of a single injection of MMC on tumor growth and morphology, serum and urine electrolytes, and ultrastructural changes in parathyroid chief cells of nude mice with the transplanted carcinoma.
Materials and Methods
Neoplastic tissue from a dog with biopsy-confirmed perirectal carcinoma derived from perianal (circumanal) glands was sliced and placed into Minimal Essential Medium (MEM) at 4 C with 50 mg/liter gentamicin sulfate (Gibco Products, Inc.). The tumor tissue was finely minced into 0.5 x 0.5 mm3 pieces and washed three times with MEM. Five female nude mice were subcutaneously implanted with 0.2 ml of a 1 : 1 mixture of minced tumor tissue and MEM. The time from collection to implantation was 24 hours. Female nude mice were obtained from Life Sciences, Inc., St. Petersburg, Florida and were maintained under barrier conditions and monitored daily. The temperature (78-82 F) and relative humidity (50 to 70%) were controlled in the animal rooms. Polycarbonate cages, rodent chow, and bedding were sterilized prior to use. Food and water were made available ad libitum and a 12-hour light-dark cycle was maintained during the experimental period. Significant difference (* = P < 0.01; t = P < 0.05; * = P < 0.001) as compared with pre-treatment values.
Tumor growth was measured twice weekly with a Vernier caliper in three dimensions. Tumor volume was calculated using the formula: %(length x width x height). The tumor doubling time (Td) in days was calculated using the formula: Td = (Ln 2)/m, where m equals the slope of the line generated by Y = m(X) + b. Y = Ln of tumor volume and X = time in days.9
Three groups of nude mice consisted of 1) nontumorbearing controls ( n = 9), 2) tumor-bearing nude mice treated with saline (n = 7), and 3) tumor-bearing mice treated with mithramycin (MMC) (n = 7). The tumor-bearing nude mice were implanted subcutaneously with a perianal carcinoma (CAC-9), and control nude mice were sham-operated. Mithramycin (Kyowa Hakko Kogyo Co, Tokyo, Japan) was dissolved in saline, and was injected intraperitoneally (8 mg/ kg) into tumor-bearing nude mice when the tumor volume 3 to 5 weeks after transplantation was at least 500 mm3 ( Table  1 ). Control nude mice were injected intraperitoneally with a comparable volume of saline. All nude mice were weighed twice weekly and euthanized two weeks after treatment.
Terminal serum samples were collected from methoxyflurane-anesthetized mice. Urine samples (0.5 ml) were collected 2 to 3 days prior to euthanasia by manual expression of the bladder and were acidified with 20 p L of 6 M HC1. Urine and serum samples were frozen at -20 C until the assays were performed. Serum calcium and urine concentrations were determined using an assay based on the cresolphthalein complexone method (Sigma Diagnostics, St. Louis, MO). Serum and urine phosphorus were determined using a colorimetric method as described by Fiske and Subbarow.5 Serum and urine creatinine were determined by the methods of Clarke.* Results were expressed as urine calcium (mg/dl) and phosphorus (mg/dl) as a ratio to creatinine (mg/dl).I3
Transplanted tumors (CAC-9) were fixed in 10% buffered formalin and embedded in paraffin. Sections were cut at 6 pm and stained with hematoxylin and eosin (HE). Maximal tumor cell diameter was made with a Zeiss Interactive Digital Analysis System (ZIDAS). Histologic evaluation of parathyroidglands ofthe nude mice were completed on 1 pm sections stained with toluidine blue which were fixed and embedded as described in methods for electron microscopy.
Histomorphometric studies were conducted on 14 female nude mice bearing the transplanted carcinoma (CAC-9) and seven nontumor-bearing controls (4 to 5 months of age). The CAC-9-bearing nude mice (seven per group) were treated with MMC or saline 2 weeks prior to euthanasia. Lumbar vertebrae were removed from the nude mice, trimmed of musculature and lateral vertebral processes, and fixed in 70% ethyl alcohol at 4 C. Vertebrae were embedded in methacrylate without decalcification. Midline horizontal sections of first or second lumbar vertebrae were cut on a Jung Model K sledge microtome. Five-pm sections were stained with von Kossa tetrachrome for measurements using brightfield light microscopy.
Static measurements were made in all vertebrae using a ZIDAS at a magnification of x 200. The parameters evaluated were endosteal perimeter (TP), Yo total resorptive surface (RS) (perimeter in mm occupied by osteoclasts and reversal lacunae), and number of osteoclasts/mm endosteal perimeter (OSC/mm). l9 Parathyroid glands and tumor tissue from representative samples were fixed in 3% buffered glutaraldehyde with 0.1 M sodium cacodylate buffer at pH 7.4, post-fixed in 1.3% osmium tetroxide in s-collidine buffer at pH 7.4, dehydrated through ascending concentrations of ethanol, transferred to polypropylene oxide, and embedded in Medcast epoxy resin (Ted Pella Inc., Tustin, CA). Ultrathin sections were stained with uranyl acetate and lead citrate, and examined with a Philips 300 electron microscope.
Statistical differences between the means for groups were evaluated using the Student's t-test. Mean values of the serum and urine calcium and phosphorus were expressed as mean tstandard error.
Results
In the initial transplant of CAC-9, four of five nude mice developed progressive subcutaneous tumor growth. The latent period from time of implantation to onset of tumor enlargement initially was 3 weeks which was reduced to 7 to 10 days in subsequent passages. Tumor-doubling interval ranged from 3.0 to 3.5 days during a 3-week logarithmic growth phase which then slowed to linear expansion of tumor volume and death of the nude mice after 5 weeks of growth. The tumor has been maintained by serial passage in nude mice up to the present passage 20.
All tumor-bearing nude mice survived throughout the experimental period. Body weight was significantly (P < 0.001) higher in the saline-treated tumor-bearing mice 2 weeks after treatment. However, there were no significant differences in body weight after treatment in the mithramycin (MMC)-treated tumor-bearing and control mice (Table 1) . Clinical signs consistent with hypercalcemia were not present in the mice with trans- A significant increase (P < 0.01) in tumor volume was present in the saline-treated tumor-bearing nude mice 2 weeks after treatment (Figs. 1,2) . MMC-treated mice had a significant decrease (P < 0.05) in tumor volume after 2 weeks compared with tumor volume before treatment ( Fig. 3 , Table 1 ). The tumor doubling rate of the saline-treated tumor-bearing nude mice was 3.1 k 0.4 days (mean f standard error).
Serum calcium levels were significantly elevated (P < 0.005) in saline-treated tumor-bearing nude mice (9.5 k 0.3 mg/dl), compared to controls (Fig. 4) . MMCtreated tumor-bearing mice had significantly decreased (P < 0.005) serum calcium levels (7.5 k 0.2 mg/dl) compared with controls. Serum phosphorus and creatinine levels were not significantly different in the tumor-bearing groups compared with controls.
Urinary excretion of calcium was increased (P < 0.05) in saline-treated tumor-bearing mice (0.085 k 0.01 8 mg Ca/mg Cr) compared to a mean of 0.05 1 k 0.007 mg Ca/mg Cr in controls (Fig. 5) . MMC-treated tumor-bearing mice (0.048 i 0.01 mg Ca/mg Cr) had a similar urinary calcium excretion as in controls. Urinary phosphorus excretion was elevated significantly (P < 0.001) in the MMC-treated tumor-bearing nude mice (5.9 k 0.1 mg P/mg Cr) as compared with controls (3.7 ? 0.1 mg P/mg Cr). There were no significant differences in urinary phosphorus excretion in salinetreated tumor-bearing mice (3.7 & 0.7 mg P/mg Cr) compared with controls.
The polyhedral tumor cells of saline-treated mice formed sheets and solid areas with abundant homogeneously eosinophilic cytoplasm. Nuclei were central and round to oval (Fig. 6 ). Few mitotic figures were present per high power field. Central necrosis was evident in scattered lobules of the tumor.
In the MMC-treated mice the few remaining viable tumor cells were larger (mean diameter ? standard deviation 29 k 4.1 pm) than in saline-treated (13.4 k 0.5 pm) mice and had an abundant eosinophilic cytoplasm ( Fig. 7 , Table 2 ). Nuclei were large, vesicular, and often contained cytoplasmic inclusions. There was a mild inflammatory response consisting primarily of neutrophils and fibrous stroma at the margin of the tumor.
Tumor cells in saline-treated nude mice had moderate cytoplasmic area with many short profiles of rough endoplasmic reticulum which contained a homogeneous granular material (Fig. 8 ). Clusters of free ribosomes were dispersed throughout the cytbplasm. A well-developed Golgi apparatus was present in most neoplastic cells. Small vesicles projected from membranes of the Golgi apparatus that either were empty or partially filled with granular material. Occasional intermediate filaments were present in the perinuclear region of most neoplastic cells from saline-treated mice. Mitochondria were numerous and varied in size and shape. Nuclei were uniformly round or oval. Plasma membranes of adjacent neoplastic cells were relatively straight with few desmosomes along cell borders (Fig.  8) .
The remaining viable tumor cells in MMC-injected mice were hypertrophied, and the large cytoplasmic area contained prominent aggregations of intermediate filaments (mean diameter 10.6 nm) that often displaced other organelles (Fig. 9 ). These filaments were in all parts of the cell, but they often were concentrated near the nucleus. The nuclear membrane of hypertrophied neoplastic cells was markedly irregular (Fig. 9) , and there were occasional inclusions of cytoplasm in the nucleus. Nuclear chromatin was dispersed, and there were prominent nucleoli. A well-developed Golgi apparatus, abundant profiles of rough endoplasmic reticulum, annulate lamellae, large mitochondria, and lipid bodies were admixed with the prominent aggregations of intermediate filaments (Fig. 10) .
Parathyroid chief cells from saline-treated tumor- bearing nude mice with mild hypercalcemia had relatively straight plasma membranes with few uncomplicated interdigitations, scattered mitochondria, only occasional electron-dense secretory granules, and infrequent lamellar arrays of endoplasmic reticulum (Fig.  1 1) . Chief cells in the active state of the secretory cycle predominated in parathyroids from MMC-treated mice with CAC-9 similar to control (nontumor bearing) mice. The electron-dense cytoplasmic area had lamellar arrays of rough endoplasmic reticulum, prominent Golgi apparatus, peripheral mature secretory granules, and often complicated interdigitations of plasma membranes. There were no significant differences in bone resorption in nude mice bearing CAC-9. The percent resorptive perimeter was numerically increased in CAC-9-bearing nude mice, but there was no significant change in the number of osteoclasts per mm endosteal surface (Table 3) .
Discussion
A serially transplantable tumor line has been developed in nude mice from a hypercalcemic canine perianal gland carcinoma (CAC-9). The tumor-doubling rate of CAC-9 was only 3.1 f 0.4 days. This was considerably faster tumor growth than reported recently for a hypercalcemic canine adenocarcinoma (CAC-8) derived from apocrine glands of the anal sac that had a tumor doubling rate of 14 days.I9 Serum calcium levels and urinary excretion of calcium of CAC-9-bearing nude mice were elevated above nontumorbearing controls but to a considerably lesser degree than for CAC-8. Hypercalcemia also has been reported in nude mice bearing transplanted tumors from human patients including squamous cell carcinoma' and renal cell carcinoma. 22 Parathyroid chief cells from CAC-9-bearing nude mice were interpreted to be in the inactive stage of the secretory cycle with relatively straight plasma membranes and occasional electron-dense secretory granules. In contrast, chief cells from nude mice bearing the canine apocrine carcinoma had ultrastructural evidence of secretory inactivity and unique concentric whorls of membrane.19 This difference probably was a reflection of the mild hypercalcemia (9.5 k 0.3 mgldl) in nude mice bearing transplanted CAC-9 compared to the severe hypercalcemia (1 6.3 * 0.6 mgldl) in mice with the transplanted anal sac carcinoma that resulted in degenerative changes of organelles.
There were no significant differences in bone re- sorption parameters of nude mice bearing the CAC-9 carcinoma compared to controls. The percent resorptive perimeter was numerically increased in CAC-9bearing nude mice with no change in the number of osteoclasts/mm endosteal surface, suggesting an increase in size of individual osteoclasts. Hypertrophy of osteoclasts without an increase in absolute numbers may have been responsible for the mild increase in serum calcium of CAC-9-bearing nude mice. Mithramycin did not significantly influence the osteoclastic perimeter or numbers in lumbar vertebrae of tumorbearing mice. The reduction of serum calcium in MMCtreated nude mice after 2 weeks may be due to functional inhibition of osteoclastic bone resorption without a corresponding reduction in osteoclast numbers. In human patients with humoral hypercalcemia of malignancy (HHM), mithramycin induces a fall in serum Urine calcium and phosphorus in CAC-9-bearing nude mice that received either saline (CAC-9) or MMC compared to controls without tumor. ty,8.16 and has been recommended in the early management of severe hypercalcemia when vigorous saline diuresis proves inadequate. 26 All MMC-treated CAC-9-bearing mice survived throughout the experimental period without significant changes in body weight. However, the tumor volume of MMC-treated mice decreased dramatically during the 2-week period until the original tumor was barely detectable macroscopically. There are several reports that MMC at doses from 2.5 to 7.2 mg/kg effectively reduces the size of tumors from human patients transplanted in nude and a mouse colon car~inoma.~ The few remaining viable CAC-9 tumor cells 2 weeks after MMC were markedly hypertrophied, and the abundant cytoplasmic area contained numerous intermediate filaments that often displaced other organelles. The significance of the prominent accumulation of in- Table 3 . Histomorphometric evaluation of lumbar vertebrae from nude mice bearing transplanted carcinoma (CAC-9) compared to nontumor-bearing controls (mean k standard error of the mean). In summary, a serially transplantable tumor (CAC-9) was developed from a canine perianal gland carcinoma that had a short (3.1 k 0.4 days) tumor-doubling rate in nude mice. The nude mice with the transplanted carcinoma developed mild hypercalcemia and increased urinary excretion of calcium within one month compared to controls. A single dose of MMC resulted in a dramatic reduction in tumor volume after 2 weeks and a return of serum and urine calcium to the control range. The remaining viable tumor cells after treatment with MMC were larger than in saline-injected tumorbearing controls and had numerous aggregations of intermediate filaments. These findings suggest that transplantable carcinoma (CAC-9) in nude mice will be a useful animal model to evaluate combinations of chemotherapy for rapidly developing cancer-associated hypercalcemia in human and animal patients.
